Summary
Pfizer Inc. (PFE) filed an 8-K on May 3, 2011, to report its financial results for the first quarter of 2011. The core of this filing is a press release, incorporated by reference, that details the company's operational and financial performance during the period ending March 31, 2011. Investors should refer to this press release for specific figures on revenue, earnings, and any forward-looking statements or strategic updates. The filing itself is procedural, serving as the official notification of the release of this information to the market. While the 8-K itself does not contain the detailed financial data, it directs investors to the accompanying press release for a comprehensive understanding of Pfizer's Q1 2011 performance. Key aspects investors would typically look for in such a release include reported earnings per share (EPS), net income, revenue growth or decline, segment performance, and any guidance provided for the remainder of the fiscal year. The effective date of the event reported is May 2, 2011, with the filing occurring on May 3, 2011.
Key Highlights
- 1Pfizer Inc. (PFE) filed an 8-K on May 3, 2011, to report Q1 2011 financial results.
- 2The filing incorporates by reference a press release dated May 3, 2011, containing the detailed financial results.
- 3Investors are directed to the press release (Exhibit 99) for specific Q1 2011 financial performance data.
- 4The report serves as official notification of the company's Q1 2011 earnings announcement.
- 5The event date for the financial results reporting was May 2, 2011.